Basivertebral nerve ablation: the newer option for "vertebrogenic" back pain

Chronic low back pain has several recognised sources, discs, facet joints, and the sacroiliac joints among the most familiar, but a less widely known source, the vertebral endplate itself, has its own name, its own specific diagnostic finding, and now its own targeted treatment. This article explains vertebrogenic back pain and basivertebral nerve ablation, the procedure developed specifically to treat it.

What makes vertebrogenic pain different

Most chronic low back pain discussions focus on the disc, the facet joints, or the sacroiliac joints as the source of pain. Vertebrogenic pain is a distinct category, originating instead from the vertebral endplate, the layer of bone and cartilage where each disc attaches to the vertebra above and below it.

This endplate can become a genuine source of chronic pain through its own process, generally understood to involve inflammation and small nerve fibres within the bone itself becoming a pain generator, a mechanism distinct from a disc bulging or a facet joint wearing down, even though all three can coexist in the same spine. This is part of why someone can have an MRI showing a mild disc bulge, some facet arthritis, and Modic changes all at the same spinal level, with each potentially contributing something to the overall pain picture rather than there being one single, simple explanation.

Recognising vertebrogenic pain as its own category matters because it responds to a different, specific treatment than the other sources, which is exactly why identifying it correctly, rather than assuming all chronic low back pain is the same, has become increasingly relevant in recent years. This increased relevance reflects a broader shift in how chronic low back pain is understood, moving away from treating it as a single, uniform condition and toward identifying the specific structure actually responsible in each individual case.

Modic changes: the finding that identifies it

Modic changes are specific patterns visible on MRI at the vertebral endplate, first described and classified decades ago, that reflect different stages of change in the bone at this location. Type 1 and type 2 are the patterns specifically associated with vertebrogenic pain.

Type 1 Modic changes generally reflect more active inflammation at the endplate, while type 2 reflects a different, somewhat more chronic pattern of fatty change in the same area. Both are visible to a radiologist reviewing an MRI and require no additional test beyond the imaging already commonly used to assess chronic back pain. This is a genuinely practical advantage, since someone who has already had an MRI for their chronic back pain may already have the key diagnostic information available, simply requiring a specific, deliberate look for this particular finding rather than an entirely new round of testing.

Identifying these changes is the key diagnostic step for considering basivertebral nerve ablation, since the procedure’s evidence base and expected benefit are specifically tied to patients who have this finding, rather than chronic low back pain in general without this specific MRI confirmation.

How basivertebral nerve ablation actually works

The basivertebral nerve is a specific small nerve that carries pain signals from the vertebral endplate to the rest of the nervous system. The procedure targets this nerve directly, rather than treating the disc, the endplate itself, or any surrounding structure.

Using imaging guidance, a thin probe is passed into the vertebral body to reach the basivertebral nerve’s location, and heat energy is then delivered through the probe to interrupt that specific nerve’s ability to transmit pain signals from the endplate going forward. This approach is conceptually similar to other nerve-targeted treatments used elsewhere in the spine, such as facet joint denervation, in that it interrupts a specific pain pathway rather than altering the structure the pain originates from.

This is a minimally invasive, typically outpatient procedure performed under some form of sedation or anaesthesia, and it is notably different in its target and mechanism from more familiar spine procedures like a disc-focused surgery or a facet joint injection, since it addresses the nerve supply to the bone rather than the disc or joint structures themselves. The typical procedure time is relatively short, generally under an hour, though this varies depending on how many spinal levels are being treated and the specific equipment and approach used by the treating centre.

Who this treatment actually suits

The typical candidate has chronic low back pain that has lasted at least six months, has tried and not achieved adequate relief from a reasonable course of conservative treatment including physiotherapy and activity modification, and has confirmed Modic type 1 or type 2 changes at the relevant spinal level on MRI.

This is a fairly specific combination, and it’s worth being clear that someone with chronic back pain but without these particular Modic changes is not considered a good candidate for this specific procedure, since the evidence supporting it is tied closely to this particular patient group. It’s also worth noting that age alone isn’t a specific inclusion or exclusion factor the way it is for some other spine procedures; the presence of the correct MRI finding matters more than age within the adult population typically affected by chronic low back pain.

A spine specialist reviewing the MRI specifically for this finding, rather than a general reading focused on disc herniation or spinal stenosis, is an important part of properly identifying who might actually benefit from this option among the broader population of people with chronic low back pain. This is one of several reasons a second, specialist-level review of existing imaging can sometimes reveal a relevant finding that a more routine initial read focused on other, more commonly searched-for issues didn’t specifically highlight.

What the evidence shows

Clinical trials studying basivertebral nerve ablation in appropriately selected patients, specifically those with confirmed Modic changes, have shown meaningful improvements in both pain scores and functional measures compared with continued conservative treatment alone in this particular group.

Some of these studies have followed patients for several years after the procedure and found the improvement was generally sustained over that time, which is a reasonably encouraging sign for a relatively newer procedure, though longer-term data continues to accumulate as more time passes since its introduction. This sustained benefit over time is a particularly relevant consideration for a procedure being weighed against alternatives, since a treatment that provides only brief relief carries a different cost-benefit calculation than one with durable results.

It’s worth being clear that these positive results are specific to the correctly selected patient group with confirmed Modic changes; applying this same procedure to chronic back pain without this specific finding would not be expected to produce the same results, which circles back to why correct patient selection matters so much here.

What recovery and outcomes typically look like

Recovery from the procedure itself is generally quick, since it is minimally invasive, with most people returning to light activity within a few days and a more complete return to normal activity over the following weeks, guided by how they’re feeling rather than a rigid universal timeline.

Pain relief isn’t always immediate, since the nerve interruption and subsequent change in pain signalling takes some time to become fully apparent, and meaningful improvement is often reported over the weeks to months following the procedure rather than immediately afterward. Setting this expectation clearly beforehand helps avoid the discouragement that can come from expecting instant relief and not seeing it in the first days after the procedure, when the actual improvement curve is naturally more gradual.

As with any procedure, results vary between individuals, and while clinical trial data is encouraging for the correctly selected group, it doesn’t guarantee a specific outcome for every single patient, which is why ongoing follow-up with the treating specialist remains part of the overall process. Honest conversations about this variability, rather than presenting the procedure as universally successful, help set expectations that match what the actual data supports.

Possible risks and limitations to understand

Like any procedure, basivertebral nerve ablation carries some general procedural risks, including the typical risks associated with sedation or anaesthesia and a small risk of infection or bleeding at the access site, which a spine specialist discusses specifically as part of informed consent before proceeding.

Because the treatment specifically targets vertebrogenic pain from Modic changes, it will not address pain coming from a different source, a disc herniation, facet joint arthritis, or sacroiliac joint dysfunction, that happens to coexist in the same person, which is why accurate identification of the actual pain generator matters so much beforehand. Someone with multiple potential contributors to their back pain might reasonably need more than one targeted treatment addressed in sequence, rather than expecting a single procedure to resolve every source simultaneously.

Not every insurance provider or healthcare system has the same level of familiarity or coverage policy for this relatively newer procedure compared with more established spine treatments, which is a practical consideration worth raising early in the conversation with both a specialist and, where relevant, an insurer. Asking directly and early about coverage, rather than discovering a gap after deciding to proceed, avoids an unnecessary and avoidable source of stress during what should otherwise be a fairly straightforward treatment decision.

As with most spine procedures, this is not expected to be a universal cure for every case it’s used for, and realistic expectations, meaningful improvement for the specific group it’s designed for, rather than a guaranteed complete resolution of all back pain, lead to more satisfying outcomes overall. A specialist who takes the time to explain exactly what the procedure can and cannot be expected to address, specifically for an individual’s own MRI findings, is generally more helpful than one offering a blanket assurance either way.

How it fits alongside other treatment options

This procedure is generally considered after conservative treatment, physiotherapy, activity modification, and appropriate pain management, has had a reasonable trial without adequate results, rather than being offered as an early or first-line option for new back pain.

It sits alongside, rather than replacing, other more established procedures for different sources of chronic low back pain, such as facet joint treatments for facet-related pain or disc-focused options for disc-related pain, each chosen based on which structure is actually identified as the source in a given person. Thinking of chronic low back pain treatment as a toolkit with several specific, targeted options, rather than a single universal approach, reflects how spine care has genuinely evolved, and basivertebral nerve ablation is one addition to that toolkit rather than a replacement for the others.

Discussing the specific MRI findings, including whether Modic changes are present, directly with a spine specialist is the practical starting point for anyone with chronic low back pain wondering whether this particular option might be relevant to their own situation.

A newer procedure in a developing evidence landscape

Basivertebral nerve ablation is genuinely newer than many other established spine treatments, which means the overall body of evidence, while encouraging, is still smaller than exists for procedures that have been used for decades, and continues to grow as more centres gain experience with it.

This doesn’t mean the current evidence should be dismissed; well-designed clinical trials with appropriately selected patients have shown real benefit, but it does mean staying informed about longer-term outcomes as more data accumulates is reasonable, both for patients considering it and for the specialists recommending it. A spine specialist who stays current with this evolving evidence base is better positioned to advise accurately than one relying on information from when the procedure was first introduced.

The specific, narrow patient selection criteria, confirmed Modic changes rather than chronic low back pain broadly, is itself a sign of a treatment being applied thoughtfully based on its actual evidence base, rather than being marketed broadly as a solution for back pain in general.

Anyone considering this procedure benefits from a direct, specific conversation about their own MRI findings and how closely their situation matches the patient group the evidence actually supports, rather than general information about the procedure alone.